Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Remo H M Furtado"'
Autor:
Satoshi Yasuda, Christopher B Granger, David B Brieger, Shaun G Goodman, Tabassome Simon, Dirk Westermann, Ruth Owen, Mauricio G Cohen, Katarina Hedman, Stuart J Pocock, Jose Carlos Nicolau, Remo H M Furtado, Phillip R Hunt
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are lim
Externí odkaz:
https://doaj.org/article/433defa176854ea4a4a5de9f5216fbd8
Autor:
Remo H. M. Furtado, Ramkumar V. Venkateswaran, Jose C. Nicolau, Yared Gurmu, Deepak L. Bhatt, Robert F. Storey, P. Gabriel Steg, Giuglia Magnani, Shinya Goto, Mikael Dellborg, Gabriel Kamensky, Daniel Isaza, Philip Aylward, Per Johanson, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea. Furthermore, association between
Externí odkaz:
https://doaj.org/article/6384ab839e054078afa8fae396ae37f5
Autor:
Marco Antonio Scanavini-Filho, Otavio Berwanger, Wilson Matthias, Miguel O. Aguiar, Hsu P. Chiang, Luciene Azevedo, Luciano M. Baracioli, Felipe G. Lima, Remo H. M. Furtado, Talia F. Dalcoquio, Fernando R. Menezes, Aline G. Ferrari, Fabio de Luca, Robert P. Giugliano, Shaun Goodman, José C. Nicolau
Publikováno v:
Advances in Therapy. 39:1832-1843
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00e9ea3ed8f4b297b6fa5fe00b9da042
https://doi.org/10.1007/s12325-022-02061-0
https://doi.org/10.1007/s12325-022-02061-0
Autor:
Paulo R. Rizzo Genestreti, Remo H. M. Furtado, Rocio Salsoso, Talia F. Dalçóquio, Andre Franci, Fernando R. Menezes, Cesar Caporrino, Aline G. Ferrari, Carlos A. K. Nakashima, Marco A. Scanavini Filho, Felipe G. Lima, Roberto R. C. V. Giraldez, Luciano M. Baracioli, Jose C. Nicolau
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5776
Background: The management of acute myocardial infarction (AMI) presents several challenges in patients with diabetes, among them the higher rate of recurrent thrombotic events, hyperglycemia and risk of subsequent heart failure (HF). The objective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcbb5b95a7da78c6f1c87258d55b9370
https://pubmed.ncbi.nlm.nih.gov/36233642
https://pubmed.ncbi.nlm.nih.gov/36233642
Autor:
Devika Aggarwal, Kirtipal Bhatia, Zainali S Chunawala, Remo H M Furtado, Debabrata Mukherjee, Simon R Dixon, Vardhmaan Jain, Sameer Arora, Thomas A Zelniker, Eliano P Navarese, Gregory J Mishkel, Cheong J Lee, Subhash Banerjee, Sripal Bangalore, Justin P Levisay, Deepak L Bhatt, Mark J Ricciardi, Arman Qamar
Publikováno v:
European Heart Journal Open. 2
Aim To compare the efficacy and safety of P2Y12 inhibitor or aspirin monotherapy for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). Methods and results Medline, Embase, and Cochrane Central databases were search
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dda09364f5de20c81a8ac79c3df2293
https://doi.org/10.1093/ehjopen/oeac019
https://doi.org/10.1093/ehjopen/oeac019
Autor:
Devika, Aggarwal, Kirtipal, Bhatia, Zainali S, Chunawala, Remo H M, Furtado, Debabrata, Mukherjee, Simon R, Dixon, Vardhmaan, Jain, Sameer, Arora, Thomas A, Zelniker, Eliano P, Navarese, Gregory J, Mishkel, Cheong J, Lee, Subhash, Banerjee, Sripal, Bangalore, Justin P, Levisay, Deepak L, Bhatt, Mark J, Ricciardi, Arman, Qamar
Publikováno v:
European heart journal open. 2(2)
To compare the efficacy and safety of P2YMedline, Embase, and Cochrane Central databases were searched to identify randomized trials comparing monotherapy with a P2YP2Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec3c06d4625a1a97dc43b0a302371f3a
https://pubmed.ncbi.nlm.nih.gov/35919116
https://pubmed.ncbi.nlm.nih.gov/35919116
Autor:
Mikhail N Kosiborod, Russell Esterline, Jan Oscarsson, Samvel B Gasparyan, Remo H M Furtado, Subodh Verma, Otavio Berwanger
Publikováno v:
The Lancet. Diabetes & Endocrinology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4760cc5bb8163871a378364a15b50d7c
https://pubmed.ncbi.nlm.nih.gov/34921752
https://pubmed.ncbi.nlm.nih.gov/34921752
Autor:
Remo H M, Furtado, Marc P, Bonaca, Itamar, Raz, Thomas A, Zelniker, Ofri, Mosenzon, Avivit, Cahn, Julia, Kuder, Sabina A, Murphy, Deepak L, Bhatt, Lawrence A, Leiter, Darren K, McGuire, John P H, Wilding, Christian T, Ruff, Jose C, Nicolau, Ingrid A M, Gause-Nilsson, Martin, Fredriksson, Anna Maria, Langkilde, Marc S, Sabatine, Stephen D, Wiviott
Publikováno v:
Circulation. 139(22)
Sodium glucose transporter-2 inhibitors reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus and a history of atherosclerotic cardiovascular disease. Because of their baseline risk, patients with pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ab4c9a25178a89d6e44c1bfbebc0cd0
https://pubmed.ncbi.nlm.nih.gov/30882236
https://pubmed.ncbi.nlm.nih.gov/30882236
Autor:
Remo H M, Furtado, Robert P, Giugliano, Talia F, Dalcoquio, Flavia B B, Arantes, Carlos J D G, Barbosa, Paulo R R, Genestreti, André, Franci, Fernando R, Menezes, Carlos A K, Nakashima, Marco A, Scanavini Filho, Aline G, Ferrari, Rocio, Salsoso, Luciano M, Baracioli, Jose C, Nicolau
Publikováno v:
Journal of thrombosis and thrombolysis. 48(2)
Recent reports have suggested that aspirin effect might be influenced by bodyweight, with decreased efficacy in heavier individuals. We investigated the influence of bodyweight on aspirin pharmacodynamics in two independent datasets of patients takin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35617ca57ea20bfa3879c95546da072d
https://pubmed.ncbi.nlm.nih.gov/30879169
https://pubmed.ncbi.nlm.nih.gov/30879169
Autor:
Thomas A, Zelniker, Stephen D, Wiviott, Itamar, Raz, KyungAh, Im, Erica L, Goodrich, Remo H M, Furtado, Marc P, Bonaca, Ofri, Mosenzon, Eri T, Kato, Avivit, Cahn, Deepak L, Bhatt, Lawrence A, Leiter, Darren K, McGuire, John P H, Wilding, Marc S, Sabatine
Publikováno v:
Journal of Diabetes Investigation
Glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) have emerged as 2 new classes of antihyperglycemic agents that also reduce cardiovascular risk. The relative benefits in patients with and with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d544630d380152021033f01d2d413b64
https://pubmed.ncbi.nlm.nih.gov/31446675
https://pubmed.ncbi.nlm.nih.gov/31446675